Chief executive, Lloyds TSB Foundation for England and Wales from 2006
Linda Kelly has been chief executive of the Lloyds TSB Foundation for England and Wales since 2006.
She was formerly chief executive of Parkinson’s UK and before that had a number of senior leadership positions in the healthcare industry, including as president of Astra Pharmaceuticals (now part of Astra Zeneca).
She is also a member of the Royal Pharmaceutical Society and a fellow of the Royal Society of Arts.
Is this profile up-to-date? If not, please let us know at email@example.com